Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Phase 1/2
25
about 6.7 years
0.0833333333333333–65
3 sites in CA
What this study is about
This trial is testing if giving patients specific T cells that fight viruses like adenovirus, cytomegalovirus, and Epstein-Barr virus can help them. The goal is to see if these T cells can improve the immune system's ability to fight off these infections in people who have weakened immunity due to previous transplants or other medical reasons.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Adenovirus Specific T- Lymphocytes
- 2.Receive Cytomegalovirus Specific T-Lymphocytes
- 3.Receive Epstein-Barr Virus Specific T-Lymphocytes
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: CTCAE Grade 4/5 Adverse Events
Secondary: Viral load by Polymerase Chain Reaction (PCR), Viral load from Bronchoalveolar lavage (BAL), Viral load from Respiratory Viral Panel (RVP), Viral load from Stool, Viral load from Urine, Viral load from fluid/tissue